使用三个国家数据源检查爱尔兰对癌症手术的COVID-19影响
Mengyang Zhang1, Caitriona Kelly2, Triona McCarthy2
1School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
Global epidemiology
|September 6, 2024
概括
COVID-19影响了爱尔兰的癌症手术,在2020年观察到最初的下降. 缓解策略,比如使用私人医院,有助于减少对癌症手术的不良影响.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 全球范围内,COVID-19大流行严重扰乱了医疗保健系统.
- 爱尔兰的医疗保健系统经历了深刻的影响,由于大流行.
研究的目的:
- 为了调查COVID-19大流行对爱尔兰癌症手术的影响.
- 利用国家数据,分析2019年至2022年癌症手术的趋势.
主要方法:
- 采用了一种重复的横截面研究设计.
- 利用了三个国家健康数据来源:国家组织病理学质量改善 (NHQI) 计划,爱尔兰国家癌症登记处 (NCRI) 和医院住院调查 (HIPE) 系统.
- 对侵袭性/in situ和仅侵袭性癌症的癌症手术数据进行了检查,重点关注乳腺,肺,结肠直肠和黑色素瘤.
主要成果:
- 2020年,每年癌症切除 (NHQI) 减少了4.4%,然后在2021年增加了4%.
- 根据NCRI数据,侵袭性癌症手术的侵袭性/in-situ下降率为14% (2020年) 和5.1% (2021年),仅侵袭性下降率为12.3% (2020年) 和7.3% (2021年).
- 高高的数据显示了类似的趋势:侵袭性/现场癌症手术下降了21.9% (2020) 和9.9% (2021),侵袭性仅下降了20.8% (2020) 和9.6% (2021).
- 无论是NHQI还是HIPE数据都表明,到2022年,癌症手术的复苏将会开始.
结论:
- 癌症手术数量最初在疫情早期的波段下降.
- 缓解措施,包括使用私人医院为公共患者,似乎减少了对癌症手术的负面影响.
- 该研究强调了爱尔兰癌症手术服务在疫情期间的弹性和适应性.
更多相关视频
04:45Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
3.7K
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
29.9K
相关概念视频
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K